Original Research

Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients

Aletaha D, Snedecor SJ, Ektare V, Xue M, Bao Y, Garg V

ClinicoEconomics and Outcomes Research 2017, 9:451-458

Published Date: 28 July 2017